Results 221 to 230 of about 100,511 (312)

Potassium channels as targets for antiarrhythmic therapy. [PDF]

Heart Rhythm
Chiamvimonvat N, Zheng Y, Zhang M.
europepmc   +1 more source

Catheter Ablation and Antiarrhythmic Drug Therapy as First- or Second-Line Therapy in the Management of Atrial Fibrillation: Systematic Review and Meta-Analysis

Circulation: Arrhythmia and Electrophysiology, 2014

semanticscholar   +1 more source

Diabetes Mellitus and Atrial Fibrillation: Mechanistic Insights and Therapeutic Impacts of Glucose-Lowering Drugs. [PDF]

Life (Basel)
Grigore M, Grigore AM, Ruxandra-Elena MG, Ioana V, Uscoiu G, Nicolae C, Balahura AM, Ilieșiu AM.   +7 more
europepmc   +1 more source

Emerging antiarrhythmic drug therapy for atrial fibrillation. [PDF]

Heart Rhythm O2
Lubitz SA, Taggart AKP, Gimpelewicz C, O'Donnell CJ.   +3 more
europepmc   +1 more source

Ibutilide: what's clinically proven, what's being investigated? [PDF]

Indian Pacing Electrophysiol J
Britto N, Das M.
europepmc   +1 more source

2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias [PDF]

, 2019
Cuculich, Phillip, et al,
core   +1 more source

Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties

Circulation, 2004
C. Antzelevitch, L. Belardinelli, A. Zygmunt, A. Burashnikov, J. M. Di Diego, J. Fish, J. Cordeiro, G. Thomas   +7 more
semanticscholar   +1 more source

Long-Term Outcomes and Post-Ablation Medication De-Escalation After Catheter Ablation for Premature Ventricular Complexes: A Nationwide Cohort Study. [PDF]

Int J Gen Med
Lin CY, Chuang CW, Chen M, Shia BC.
europepmc   +1 more source